CHMG vs CARE
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Nov 08, 2026
CHMG
CARE
Investment Advisor Scores
CARE
AI Analyst Insights
Detailed Metrics Comparison
| Metric | CHMG | CARE | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 9.2937 | 13.6612 | CHMG |
| PEG Ratio | 0 | 0 | Tie |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | 24.8% | 0.1% | CHMG |
| Earnings Growth | 62.1% | 45.8% | CHMG |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 51.8/100 | 49.0/100 | CHMG |
| Profit Margin | 31.0% | 45.7% | CARE |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | HOLD | HOLD | Tie |
Relative Price Performance (Last 90 Days)
Current Technical Phase
CHMG
MarkupPrice above SMA50, rising 50-day trend (0.8% over 20 days), RSI 59
CARE
DistributionPrice near a flattening SMA50 (slope -3.2%) with fading momentum, RSI 46
Fundamentals Snapshot
| Metric | CHMG | CARE |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | 10.2 | 11.8 |
| Trailing P/E | 10.8 | 5.0 |
| Revenue (TTM) | — | — |
| Revenue Growth | 0.2% | 0.0% |
| Gross Margin | 1.0% | 1.0% |
| Operating Margin | 0.5% | 0.2% |
| EPS | 7.97 | 5.91 |
| Dividend Yield | 0.02% | 0.01% |